AX Pharmaceutical Corp
- Manufacturer
- AX Pharmaceutical Corp
- Effective date
- 2018-09-19
- Label type
- BULK INGREDIENT
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:49:07
Label at a glance#
ProductAX Pharmaceutical Corp
Active ingredientATOVAQUONE
Label structure1 sections
Label contents#
Full prescribing information#
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 4a3a9d58-de64-b317-9153-f2c3fc3a43c9 | Product name | 8 | 20220517 |
| 7beb5026-9819-5e26-fae7-eca2788430de | Product name | 2 | 20150108 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62157-674-01 | AX Pharmaceutical Corp | 50 g in 1 JAR | POWDER | 50 | 1 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- AX Pharmaceutical Corp
- ATOVAQUONE
- WATER
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 62157-674 | 62157-674-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ATOVAQUONE | Y883P1Z2LT | ACTIB |
| WATER | 059QF0KO0R | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Atovaquone Oral Suspension | ATOVAQUONE | KVK-Tech, Inc. | b31ff20a-c363-4be0-9bc0-3081c163b63c | 2026-06-16 | Warnings, Adverse reactions | ATOVAQUONE |
| ATOVAQUONE | ATOVAQUONE | AvKARE | 54423fee-da60-25dc-e063-6294a90a2552 | 2026-06-14 | Warnings, Adverse reactions | ATOVAQUONE |
| Atovaquone | ATOVAQUONE | Camber Pharmaceuticals, Inc. | 2445304e-4b4e-4358-b098-31f3c49c52ef | 2026-06-10 | Warnings, Adverse reactions | ATOVAQUONE |
| atovaquone | ATOVAQUONE | Glenmark Pharmaceuticals Inc., USA | 9045ba6f-938e-4717-bfa2-a3efe52f04cd | 2026-05-06 | Warnings, Adverse reactions | ATOVAQUONE |
| Atovaquone | ATOVAQUONE | PAI Holdings, LLC dba PAI Pharma | df6086d3-6100-422a-bf23-e9610027749b | 2026-04-30 | Warnings, Adverse reactions | ATOVAQUONE |
| ATOVAQUONE | ATOVAQUONE | Amneal Pharmaceuticals LLC | b7398fcf-522a-488a-8dd6-051561f62804 | 2026-04-29 | Warnings, Adverse reactions | ATOVAQUONE |
| MEPRON | ATOVAQUONE | GlaxoSmithKline LLC | b426b6bf-f07e-4580-97ae-dfca1ddf5b8f | 2026-03-20 | Warnings, Adverse reactions | ATOVAQUONE |
| Atovaquone Oral Suspension | ATOVAQUONE | Kesin Pharma Corporation | 4a2e2c4b-85aa-9b30-e063-6294a90a7bd9 | 2026-02-06 | Warnings, Adverse reactions | ATOVAQUONE |
| Atovaquone | ATOVAQUONE | Golden State Medical Supply, Inc. | ddbfe1a9-df9b-79b0-e053-2995a90acc9b | 2025-12-17 | Warnings, Adverse reactions | ATOVAQUONE |
| Atovaquone | ATOVAQUONE | Bionpharma Inc. | bff4f4fc-6307-f414-e053-2a95a90ac0de | 2025-12-04 | Warnings, Adverse reactions | ATOVAQUONE |
| Atovaquone | ATOVAQUONE | Chartwell Governmental & Specialty RX, LLC. | e6770b85-54f8-4969-af02-7d81586be761 | 2025-11-07 | Warnings, Adverse reactions | ATOVAQUONE |
| Atovaquone | ATOVAQUONE | American Health Packaging | 1a8a43a2-bc26-4ee5-aa35-22a5477a7129 | 2025-10-17 | Warnings, Adverse reactions | ATOVAQUONE |
| ATOVAQUONE | ATOVAQUONE | AvPAK | 4124ad97-f6b9-8afb-e063-6294a90ab970 | 2025-10-14 | Warnings, Adverse reactions | ATOVAQUONE |
| Atovaquone | ATOVAQUONE | ATLANTIC BIOLOGICALS CORP. | 40331de7-819e-5965-e063-6294a90ac91d | 2025-10-01 | Warnings, Adverse reactions | ATOVAQUONE |
| Atovaquone | ATOVAQUONE | Kesin Pharma | 16b69156-e5de-c601-e063-6394a90afeae | 2025-09-15 | Warnings, Adverse reactions | ATOVAQUONE |
| Atovaquone | ATOVAQUONE | ATLANTIC BIOLOGICALS CORP. | f99a8a0c-2b42-4da0-8f5a-e963fc619e8b | 2025-05-12 | Warnings, Adverse reactions | ATOVAQUONE |
| Atovaquone | ATOVAQUONE | Abon Pharmaceuticals, LLC | 2d3715ed-6ddc-4c10-9d2c-9c80cb1dfd08 | 2025-05-12 | Warnings, Adverse reactions | ATOVAQUONE |
| Atovaquone | ATOVAQUONE | Lohxa | ba3cad0d-cce9-424f-ba5c-557dba8bef12 | 2025-03-20 | Warnings, Adverse reactions | ATOVAQUONE |
| Atovaquone | ATOVAQUONE | Chartwell RX, LLC | de0e29b5-a4c7-405c-a5b9-438729d9ba3a | 2024-05-24 | Warnings, Adverse reactions | ATOVAQUONE |
| Atovaquone | ATOVAQUONE | NorthStar RxLLC | fc7bdd97-f780-4eed-80e0-72e70267b21a | 2024-04-12 | Warnings, Adverse reactions | ATOVAQUONE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
